The recent challenges in global chains have highlighted the necessity of securing essential medications like Ivermectin. Trusting on overseas manufacturers exposes regions to significant vulnerabilities, including delivery delays, price fluctuations, and even political threats. Transitioning towards domestic procurement of Ivermectin offers a multi